Literature DB >> 12929058

A prospective randomized comparison of unsedated ultrathin versus standard esophagogastroduodenoscopy in routine outpatient gastroenterology practice: does it work better through the nose?

B Birkner1, N Fritz, W Schatke, J Hasford.   

Abstract

BACKGROUND AND STUDY AIMS: In an outpatient gastroenterological practice setting, highly effective diagnostic procedures and patient satisfaction play an important role. Ultrathin endoscopy in unsedated patients has been shown to be more cost-effective and time-efficient in comparison with standard endoscopy. A prospective randomized study was carried out in unsedated patients to compare performance, feasibility, safety, and patient tolerance between ultrathin transnasal (UT), ultrathin oral (UO), and standard (SO) esophagogastroduodenoscopy (EGD). PATIENTS AND METHODS: A total of 200 of 600 eligible patients consented to participate in the study, and were randomly assigned to undergo UT, UO, or SO. Patients reported their tolerance of the procedure (anxiety, pain, gagging, and overall satisfaction; Likert scale 1-10), and the endoscopists reported the effectiveness of the procedure (handling, picture quality, and overall performance; Likert scale 1-10). Statistics were calculated using the Kruskal-Wallis test.
RESULTS: After randomization, 65, 67, and 68 patients were allocated to the UT, UO, and SO groups, respectively. Failure to achieve complete EGD by the intended route occurred in 14 patients (22 %) in the UT group. Compared to the SO group, patients in the UT and UO groups rated anxiety before the procedure as being more intense - median score (10 % quantile estimate; 90 % quantile estimate): UT, 2.0 (1.0; 4.0); UO, 2.0 (1.0; 4.0); SO, 0.0 (0.0; 2.0); p < 0.0001), whereas SO patients experienced a higher level of anxiety during the procedure ( P < 0.0001). Pain during insertion of the endoscope was the least intense in the UO group: UT, 2.0 (1.0; 5.0); UO, 1.0 (1.0; 3.0); SO, 2.0 (1.0; 4.0); P < 0.001). Gagging during insertion was more pronounced in the UO group: UT, 2.0 (1.0; 4.0); UO, 3.0 (1.0; 7.0); SO, 2.0 (1.0; 5.0); P < 0.01). The patients' score for the overall assessment was better in the SO group ( P < 0.0001). The endoscopists' overall assessment for ultrathin EGD was poorer than for standard EGD: UT, 3.0 (2.0; 5.0); UO, 3.0 (2.0; 5.0); SO, 2.0 (1.0; 3.0); P < 0.0001).
CONCLUSIONS: Ultrathin endoscopy through both the transnasal and oral routes has limited use in routine outpatient practice. Techniques for reducing pain and gagging may improve patient tolerance. Further technical improvements are needed to allow routine implementation.

Entities:  

Mesh:

Year:  2003        PMID: 12929058     DOI: 10.1055/s-2003-41523

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  21 in total

1.  Transnasal endoscopic retrograde chalangiopancreatography using an ultrathin endoscope: a prospective comparison with a routine oral procedure.

Authors:  Akihiro Mori; Noritsugu Ohashi; Takako Maruyama; Hideharu Tatebe; Katsuhisa Sakai; Takashi Shibuya; Hiroshi Inoue; Shoudou Takegoshi; Masataka Okuno
Journal:  World J Gastroenterol       Date:  2008-03-14       Impact factor: 5.742

2.  Diagnosis of endoscopic Barrett's esophagus by transnasal flexible spectral imaging color enhancement.

Authors:  Hiroyuki Osawa; Hironori Yamamoto; Naoshi Yamada; Mitsuyo Yoshizawa; Keijiro Sunada; Hiroto Kita; Hironari Ajibe; Kiichi Satoh; Kentaro Sugano
Journal:  J Gastroenterol       Date:  2009       Impact factor: 7.527

3.  A randomized trial of topical anesthesia comparing lidocaine versus lidocaine plus xylometazoline for unsedated transnasal upper gastrointestinal endoscopy.

Authors:  Justin Cheung; Karen Goodman; Robert Bailey; Richard Fedorak; John Morse; Mario Millan; Tom Guzowski; Sander Veldhuyzen van Zanten
Journal:  Can J Gastroenterol       Date:  2010-05       Impact factor: 3.522

4.  Unsedated transnasal esophagoscopy for monitoring therapy in pediatric eosinophilic esophagitis.

Authors:  Joel A Friedlander; Emily M DeBoer; Jason S Soden; Glenn T Furuta; Calies D Menard-Katcher; Dan Atkins; David M Fleischer; Robert E Kramer; Robin R Deterding; Kelley E Capocelli; Jeremy D Prager
Journal:  Gastrointest Endosc       Date:  2015-07-02       Impact factor: 9.427

5.  Transnasal endoscopy: no gagging no panic!

Authors:  Clare Parker; Estratios Alexandridis; John Plevris; James O'Hara; Simon Panter
Journal:  Frontline Gastroenterol       Date:  2015-07-02

6.  Ultraslim endoscopy with flexible spectral imaging color enhancement for upper gastrointestinal neoplasms.

Authors:  Yukari Tanioka; Hideo Yanai; Eiki Sakaguchi
Journal:  World J Gastrointest Endosc       Date:  2011-01-16

7.  Diagnostic utility of small-caliber and conventional endoscopes for gastric cancer and analysis of endoscopic false-negative gastric cancers.

Authors:  Hiromi Kataoka; Kiyoshi Mizuno; Noriyuki Hayashi; Mamoru Tanaka; Hirotaka Nishiwaki; Masahide Ebi; Tsutomu Mizoshita; Yoshinori Mori; Eiji Kubota; Satoshi Tanida; Takeshi Kamiya; Takashi Joh
Journal:  World J Gastrointest Endosc       Date:  2013-09-16

8.  Monitored anesthesia care with propofol versus surgeon-monitored sedation with benzodiazepines and narcotics for preoperative endoscopy in the morbidly obese.

Authors:  Atul K Madan; David S Tichansky; Johnathan Isom; Gayle Minard; Tiffany K Bee
Journal:  Obes Surg       Date:  2008-05       Impact factor: 4.129

9.  Early experience with unsedated ultrathin 4.9 mm transnasal gastroscopy: a pilot study.

Authors:  Justin Cheung; Robert Bailey; Sander Veldhuyzen van Zanten; Ross McLean; Richard N Fedorak; John Morse; Mario Millan; Tom Guzowski; Karen J Goodman
Journal:  Can J Gastroenterol       Date:  2008-11       Impact factor: 3.522

10.  Linked color imaging technology facilitates early detection of flat gastric cancers.

Authors:  Hisashi Fukuda; Yoshimasa Miura; Yoshikazu Hayashi; Takahito Takezawa; Yuji Ino; Masahiro Okada; Hiroyuki Osawa; Alan K Lefor; Hironori Yamamoto
Journal:  Clin J Gastroenterol       Date:  2015-11-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.